Evidence map›Paper›PMID 32620110›Full record

ArticleBMC biology2020

AIMTOR, a BRET biosensor for live imaging, reveals subcellular mTOR signaling and dysfunctions.

Nathalie Bouquier, Enora Moutin, Lionel A Tintignac, Amandine Reverbel, Elodie Jublanc, Michael Sinnreich, Yan Chastagnier, Julien Averous, Pierre Fafournoux, Chiara Verpelli and 4 more

Open access · goldAbstract read
In one paragraph

Article in BMC biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Conformation-specific synthetic intrabodies modulate mTOR signaling with subcellular spatial resolution.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 5 countries.

Nathalie BouquierIGF, University of Montpellier, CNRS, INSERM, Montpellier, France.
Enora MoutinIGF, University of Montpellier, CNRS, INSERM, Montpellier, France.
Lionel A TintignacUniversity Hospital Basel, Department of Biomedecine, Basel, Switzerland.
Amandine ReverbelDMEM, University of Montpellier, INRAE, Montpellier, France.
Elodie JublancDMEM, University of Montpellier, INRAE, Montpellier, France.
Michael SinnreichUniversity Hospital Basel, Department of Biomedecine, Basel, Switzerland.
Yan ChastagnierIGF, University of Montpellier, CNRS, INSERM, Montpellier, France.
Julien AverousUniversité Clermont Auvergne, INRAE, Unité de Nutrition Humaine, UMR1019, Clermont-Ferrand, France.
Pierre FafournouxUniversité Clermont Auvergne, INRAE, Unité de Nutrition Humaine, UMR1019, Clermont-Ferrand, France.
Chiara VerpelliCnr Institute of Neuroscience, Via Vanvitelli, 3220129, Milan, Italy.
Tobias BoeckersAnatomie und Zellbiologie Universität Ulm, Albert-Einstein Allee 11, Raumnummer 4105, M24, 89081, Ulm, Germany.
Gilles CarnacPhymedexp, University of Montpellier, CNRS, INSERM, Montpellier, France.
Julie PerroyIGF, University of Montpellier, CNRS, INSERM, Montpellier, France. julie.perroy@igf.cnrs.fr.
Vincent OllendorffDMEM, University of Montpellier, INRAE, Montpellier, France. vincent.ollendorff@inrae.fr.ORCID 0000-0001-9751-2202
Centre National de la Recherche Scientifique · FRUniversité Clermont Auvergne · FRUniversité de Montpellier · FRUniversity Hospital of Basel · CHInstitut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement · FRNeuroscience Institute · ITUniversität Ulm · DE

Funding

Agence Nationale de la Recherche ANR-13-JSV4-0005-01Conseil Régional Languedoc-Roussillon chercheur d'avenirEuropean Research Council grant agreement No. 646788
6 · The paper itself

Abstract

backgroundmTOR signaling is an essential nutrient and energetic sensing pathway. Here we describe AIMTOR, a sensitive genetically encoded BRET (Bioluminescent Resonance Energy Transfer) biosensor to study mTOR activity in living cells.

resultsAs a proof of principle, we show in both cell lines and primary cell cultures that AIMTOR BRET intensities are modified by mTOR activity changes induced by specific inhibitors and activators of mTORC1 including amino acids and insulin. We further engineered several versions of AIMTOR enabling subcellular-specific assessment of mTOR activities. We then used AIMTOR to decipher mTOR signaling in physio-pathological conditions. First, we show that mTORC1 activity increases during muscle cell differentiation and in response to leucine stimulation in different subcellular compartments such as the cytosol and at the surface of the lysosome, the nucleus, and near the mitochondria. Second, in hippocampal neurons, we found that the enhancement of neuronal activity increases mTOR signaling. AIMTOR further reveals mTOR-signaling dysfunctions in neurons from mouse models of autism spectrum disorder.

conclusionsAltogether, our results demonstrate that AIMTOR is a sensitive and specific tool to investigate mTOR-signaling dynamics in living cells and phenotype mTORopathies.

Indexed as

Signal TransductionAnimalsBiosensing TechniquesDiagnostic ImagingHEK293 CellsHumansMiceQuadriceps MuscleTOR Serine-Threonine KinasesMTOR protein, humanTOR Serine-Threonine KinasesAutism spectrum disorderBRETmTORC1 BiosensormToropathiesmTor signalingMuscle differentiationNeuronal activity

Identifiers

PMID32620110
PMCPMC7334845
OpenAlexW3039706591

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.